BerGenBio ASA (OSL:BGBIO)
Norway · Delayed Price · Currency is NOK 1.180
0.00 (0.00%)
Jul 16, 2025, 2:05 PM CET
BerGenBio ASA Revenue
In the year 2024, BerGenBio ASA had annual revenue of 848.00K NOK with 139.55% growth. BerGenBio ASA had revenue of 681.00K in the quarter ending December 31, 2024, with 92.37% growth.
Revenue
848.00K
Revenue Growth
+139.55%
P/S Ratio
54.39
Revenue / Employee
65.23K
Employees
13
Market Cap
46.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 848.00K | 494.00K | 139.55% |
| Dec 31, 2023 | 354.00K | -35.00K | -9.00% |
| Dec 31, 2022 | 389.00K | -385.00K | -49.74% |
| Dec 31, 2021 | 774.00K | 173.00K | 28.79% |
| Dec 31, 2020 | 601.00K | -8.30M | -93.25% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 603.92M |
| Nordhealth AS | 545.88M |
| Photocure ASA | 532.69M |
| Omda AS | 442.14M |
| Vistin Pharma ASA | 440.66M |
| Gentian Diagnostics ASA | 163.38M |
| ArcticZymes Technologies ASA | 102.97M |
| Lytix Biopharma AS | 608.00K |
BerGenBio ASA News
- 4 months ago - BerGenBio ASA (STU:7BG0) Q4 2024 Earnings Call Highlights: Strategic Review and Financial ... - GuruFocus